Kanata’s Evidence Partners Shine Through Their COVID-19 Research
Demand for Evidence Partners’ DistillerSR, which streamlines the medical research process for academics and health organizations has skyrocketed during the [...]
Town Hall Meeting Sparks Thought-provoking Discussion About US Healthcare Spending
A diverse group of health care experts and stakeholders participated in the Going Below The Surface (GBTS) Forum’s first ever [...]
Racial Biases Persist in Widely-used Analytics Software
According to a recent article published by Casey Ross of Stat News, infusion of bias into decisions about who should [...]
Pay-for-Performance Program Increased Evidence-Based Prescribing of Cancer Drugs
Increased prescribing rates of evidence-based cancer drugs may be achieved without a concomitant change in total spending on care through [...]
[Webinar] Digital Innovation and the Field Medical Role: Where Medical Affairs Can Show its Mettle During COVID-19
Tune in tomorrow, Oct 15 at 10:00 AM EST, for a special 75-minute MAPS Global Town Hall in which a [...]
How Should Value-based Care Be Implemented?
Value-based care is already proven to work, so the question now is how to best implement it. One possibility would [...]
What’s the Evidence for HTA?
In this blog, Dalia Dawoud, Scientific Adviser at NICE Science, Evidence and Analytics Directorate, explains NICE’s role as co-host of [...]
Amazon, Apple, Facebook, and Google Target the Health Insurance Market
According to a recent analysis and report published by CB Insights, Amazon, Apple, Facebook, and Google have been able to [...]
The Shifting Evidence Landscape in the Era of COVID-19
There is extreme pressure on governments, researchers, and health care providers to deliver effective, evidence-based approaches to the prevention, detection, [...]
What Post-pandemic changes Would Patients Like to See Continue?
CoverMyMeds recently performed a patient survey which also heavily informed the COVID-19 & Medication Access report. In the survey, patients [...]
[Webinar] Patient-Focused Medicines Development During COVID-19
The COVID-19 pandemic has turned the lives of many patients upside down by adding additional layers of complexity. How exactly [...]
[Virtual Seminar] Statistics for the Non-Statistician
Join Steven Wachs on Thursday, October 15, 2020 at 11:00 AM EDT for a 6-Hour Virtual Seminar on Statistics for [...]
Ethnoracial Disparities Pervasive in Clinical Research
As clinical trials are the gold standard for evidence-based medicine, it is essential for researchers to be as inclusive as [...]
Researchers Perform Integrative Review of Managed Entry Agreements
Managed entry agreements (MEAs) are of group of instruments designed to reduce the budget impact, uncertainty, and risk of expensive [...]
What COVID-19 Can Teach Us About Real World Data
Due to the urgent need to characterize and track the spread of COVID-19, good healthcare data have been highly sought [...]
WHO’s New Pricing Policy Guideline Makes Medicines More Affordable
A new WHO guideline aims to help governments overcome the barrier of high prices for pharma products, enabling them to [...]
[Webinar] Bayesian Statistics and FDA Regulatory Acceptability
Bayesian statistics have been used in regulatory submissions to the Food and Drug Administration (FDA) for over 15 years in [...]
Size Doesn’t Matter: A Small Biotech Plays Big with Payer Engagement
Last month, Dr. Patti Peeples, CEO of HealthEconomics.Com, interviewed Allen Lising on how Xcenda’s FormularyDecisions™ is used early in drug development [...]
[Webinar] Multi-Criteria Decision Analysis: Can It Help Make Value Assessment More Patient-Centered?
Researchers, value assessors, and the patient community agree that traditional means of value assessment often do not factor in the [...]
Geographic Bias Present in Medical AI Tools
Historically, diversity has not been a serious consideration in the minds of researchers when studying new medications. Most clinical trials [...]
How Can Specialty Pharmacy Thrive in the New Era of Value?
The days of fee-for-service health care are coming to an end, with value-based initiatives that improve patient outcomes, reduce cost, [...]
CADTH Resumes Scientific Advice Activities
CADTH just announced that they have resumed activities in their Scientific Advice Program and are once again accepting applications for [...]
NICE Seeks to Simplify Selection Process for Drug and Medical Device Evaluation
NICE is seeking public input on changing the process it uses to selects the topics it develops guidance on. The [...]
The Trouble With List Prices
This week, the RAND Corporation issued a new report highlighting that US list prices on insulin are 8.1 times higher than [...]
ICER Launches Customizable COVID-19 Cost-Effectiveness Model
The Institute for Clinical and Economic Review (ICER) announced the launch of a cloud-based platform that allows customization of model [...]